COMMUNIQUÉS West-GlobeNewswire

Agile Therapeutics Resubmits New Drug Application (NDA) for its Transdermal Low-Dose Contraceptive Patch, Twirla®
17/05/2019
PRINCETON, N.J., May 17, 2019 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it has resubmitted to the U.S. Food and Drug Administration (FDA) the NDA for its [...]
ADMA Biologics Announces Pricing of Public Offering of Common Stock
17/05/2019
RAMSEY, N.J. and BOCA RATON, Fla., May 17, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”) a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company [...]
Natus to Present at William Blair 39th Annual Growth Stock Conference
17/05/2019
PLEASANTON, Calif., May 17, 2019 (GLOBE NEWSWIRE) -- Natus Medical Incorporated (NASDAQ: BABY) today announced that Drew Davies, Executive Vice President and Chief Financial Officer will present at the William Blair 39 [...]
Achillion Reports Positive Interim Data for ACH-4471 Phase 2 Combination Trial with Eculizumab at The New Era of Aplastic Anemia and PNH Meeting
17/05/2019
- ACH-4471 increased hemoglobin and nearly eliminated the need for transfusions in patients with PNH being treated with C5 inhibitor, eculizumab - BLUE BELL, Pa., May 17, 2019 (GLOBE NEWSWIRE) -- Achillion [...]
Pulmocide presents clinical update from promising antifungal program at 2019 Respiratory Innovation Summit
17/05/2019
Pulmocide presents clinical update from promising antifungal program at 2019 Respiratory Innovation Summit London, UK; 17 May 2019 – Pulmocide Ltd, which is developing first-in-class inhaled anti-infectives for targeted [...]
Arch Biopartners Arranges Convertible Note Financing
17/05/2019
TORONTO, May 17, 2019 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced it has arranged a non-brokered, unsecured convertible note (“Note”) financing [...]
Mesoblast to Present at 2019 RBC Capital Markets Global Healthcare Conference
17/05/2019
NEW YORK and MELBOURNE, Australia, May 17, 2019 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq: MESO; ASX: MSB), global leader in cellular medicines for inflammatory diseases, today announced an upcoming corporate [...]
Terveystalo's network of occupational health services to expand: Terveystalo to acquire Työsyke Oy in Kanta-Häme
17/05/2019
Press release 17 May 2019 The owners of Työsyke Oy, the city of Hämeenlinna, the municipality of Kanta-Häme Hospital District, the city of Riihimäki, the municipality of the Riihimäki Region Health Center, the [...]
Biocartis Group NV: Disclosure of a transparency notification
17/05/2019
PRESS RELEASE : REGULATED INFORMATION 17 May 2019, 07:00 CEST Disclosure of a transparency notification Mechelen, Belgium, 17 May 2019 - Biocartis Group NV (the 'Company' or 'Biocartis'), an innovative molecular [...]
Curetis Announces Financial Results for the First Three Months of 2019
17/05/2019
Curetis Announces Financial Results for the First Three Months of 2019 - Total year-on-year revenue growth of approximately 45% - Successful implementation of corporate re-organization and significant reduction of cost [...]
Ascent Industries Provides Update on the Filing of Its Annual Financial Statements, Special Meeting of Shareholders and Annual General Meeting
17/05/2019
VANCOUVER, British Columbia, May 16, 2019 (GLOBE NEWSWIRE) -- Ascent Industries Corp. ( CSE: ASNT ) (“ Ascent ”) announced today that the Company has not filed its annual financial statements, the related management’s [...]
Avricore Health Provides Update on Status of Management Cease Trade Order
16/05/2019
Vancouver, May 16, 2019 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR) (“Avricore Health” or the “Company”) is providing this update on the status of a management cease trade order granted on May 2, 2019 (the " [...]
Publication in blood® Highlights Potential for GM-CSF Neutralization as a Solution for CAR-T Induced Neurotoxicity
16/05/2019
Severe neurotoxicity (NT) is a negative prognostic factor for overall survival with chimeric antigen receptor T-cell (CAR-T) therapy Prolonged exposure of corticosteroids for severe NT may negatively in fl uence overall [...]
Antares Pharma to Present at the B. Riley FBR Institutional Investor Conference
16/05/2019
EWING, N.J., May 16, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Fred M. Powell, Executive Vice President and Chief Financial Officer, will present at the B. Riley FBR Institutional [...]
The Cooper Companies to Present at William Blair Growth Stock Conference
16/05/2019
PLEASANTON, Calif., May 16, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) will present at the William Blair Growth Stock Conference in Chicago, IL, on June 5, 2019. Brian G. Andrews, Senior Vice [...]
Kane Biotech Announces First Quarter 2019 Earnings Conference Call and Business Update
16/05/2019
Conference Call to be held Thursday, May 23 at 4:30pm ET WINNIPEG, Manitoba, May 16, 2019 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the [...]
Vascepa® to Be Featured in Multiple Scientific Sessions at the National Lipid Association Annual Meeting
16/05/2019
Vascepa’s REDUCE-IT Trial Impact on Clinical Practice an Important Highlight BEDMINSTER, N.J. and DUBLIN, Ireland, May 16, 2019 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a pharmaceutical company focused [...]
Teladoc Health to Participate in Upcoming Investor Conferences
16/05/2019
PURCHASE, NY, May 16, 2019 (GLOBE NEWSWIRE) -- Teladoc Health , Inc. (NYSE: TDOC), the global leader in virtual care, announced today that Jason Gorevic, chief executive officer, will participate in the following [...]
Axovant Announces Dosing of First Patient in Clinical Program for AXO-AAV-GM1, a Novel Gene Therapy for GM1 Gangliosidosis
16/05/2019
- Milestone marks the first patient with GM1 gangliosidosis treated with gene therapy- -Initial data expected in second half of 2019- -AXO-AAV-GM1 is Axovant’s third investigational gene therapy program to enter the [...]

Pages